International development of a patient-centered core outcome set for assessing health-related quality of life in metastatic breast cancer patients

K. M. de Ligt,B. H. de Rooij,E. Hedayati,M. M. Karsten,V. R. Smaardijk,M. Velting,C. Saunders,L. Travado,F. Cardoso,E. Lopez,N. Carney,Y. Wengström,A. Ives,G. Velikova,M. D. L. Sousa Fialho,Y. Seidler,T. A. Stamm,L. B. Koppert,L. V. van de Poll-Franse,the Innovative Medicines Initiative - Health Outcomes Observatory (H2O) consortium
DOI: https://doi.org/10.1007/s10549-022-06827-6
2023-01-22
Breast Cancer Research and Treatment
Abstract:For patients living with metastatic breast cancer (MBC), achieving best possible health-related quality of life, along with maximizing survival, is vital. Yet, we have no systemic way to determine if we achieve these goals. A Core Outcome Set (COS) that allows standardized measurement of outcomes important to patients, but also promotes discussing these outcomes during clinical encounters, is long overdue.
oncology
What problem does this paper attempt to address?